Importance of the long-acting partner drug in artemisinin-based combination therapy

Expert Review of Clinical Pharmacology

Volumn 1, Issue 6, 2008, Pages 745-747

  Kurtzhals, Jørgen A L ^a,b,c  

^a Mental Health Services CPH   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; AMODIAQUINE PLUS ARTESUNATE; ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ; ARTESUNATE; CHLOROQUINE; DIHYDROARTEMISININ PLUS PIPERAQUINE; EURARTESIM; FANSIDAR; MEFLOQUINE; METAKELFIN; PYRONARIDINE; SULFALENE; UNCLASSIFIED DRUG;

AFRICA; ANTIMALARIAL ACTIVITY; ANTIMALARIAL DRUG RESISTANCE; AREA UNDER THE CURVE; CLINICAL TRIAL; CONFERENCE PAPER; DRUG DISTRIBUTION; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG SAFETY; DRUG TREATMENT FAILURE; FOOD; FOOD DRUG INTERACTION; GASTROINTESTINAL DISEASE; HUMAN; MALARIA; MAXIMUM PLASMA CONCENTRATION; SUSPENSION; TABLET; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VOMITING;

EID: 70049092191     PISSN: 17512433     EISSN: None     Source Type: Journal    
DOI: 10.1586/17512433.1.6.745     Document Type: Conference Paper

References (6)

1. Penali LK, Jansen FH. Single-day, three-dose treatment with fixed-dose combination artesunate/sulfamethoxypyrazine/pyrimethamine to cure Plasmodium falciparum malaria. Int. J. Infect. Dis. 12(4), 430-437 (2008).
2. Ramharter M, Kurth F, Schreier AC et al. Fixed-dose pyronaridine-artesunate combination for treatment of uncomplicated falciparum malaria in pediatric patients in Gabon. J. Infect. Dis. 198(6), 911-919 (2008).
3. Zongo I, Dorsey G, Rouamba N et al. Artemether - lumefantrine versus amodiaquine plus sulfadoxine - pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial. Lancet 369(9560), 491-498 (2007).
4. Adjei GO, Kurtzhals JA, Rodrigues OP et al. Amodiaquine - artesunate vs artemether - lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up. Malar. J. 7, 127 (2008).
5. Ashley EA, Stepniewska K, Lindegardh N et al. How much fat is necessary to optimize lumefantrine oral bioavailability? Trop. Med. Int. Health 12(2), 195-200 (2007).
6. Abdulla S, Sagara I, Borrmann S et al. Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trial. Lancet DOI:10.1016/S0140-6736(08)61492-0 (2008).